Horan Christopher

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Horan Christopher's trades of Artiva Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-19
S Sale
79,109 +14.9%
334.87
US$4,175,276 		79,109 +14.9% 334.87 US$4,175,276
2026-05-18 2026-05-18
PrS Proposed sale
22,262
386.34
US$2,419,910 		22,262 386.34 US$2,419,910